Long-term treatment of hypertension with methyldopa. VIII. Overview

Abstract

A multiclinic retrospective study in patients who received methyldopa, some for up to 10 years, has provided a large body of long-term data on the efficacy and tolerability of the drug as part of an antihypertensive regimen. Blood pressure and dosage data were analyzed over the first 4.5 years. The results of this survey are summarized here.